The Aging Risk and Atherosclerosis: A Fresh Look at Arterial Homeostasis
暂无分享,去创建一个
Pascal J. Goldschmidt-Clermont | Sylvia Daunert | S. Daunert | P. Goldschmidt-Clermont | Trajen Head | Trajen Head
[1] Klaus Ley,et al. Monocyte trafficking across the vessel wall. , 2015, Cardiovascular research.
[2] Paul C. Evans,et al. The role of blood flow in determining the sites of atherosclerotic plaques , 2011, F1000 medicine reports.
[3] F. Tacke,et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. , 2007, The Journal of clinical investigation.
[4] M. Pencina,et al. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.
[5] J. Mehta,et al. Oxidized LDL, LOX-1 and Atherosclerosis , 2011, Cardiovascular Drugs and Therapy.
[6] Carmela Rita Balistreri,et al. Cellular and molecular basis of the imbalance between vascular damage and repair in ageing and age-related diseases: As biomarkers and targets for new treatments , 2016, Mechanisms of Ageing and Development.
[7] A. Heldman,et al. Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial , 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.
[8] C. Weber,et al. Chemokines and their receptors in Atherosclerosis , 2015, Journal of Molecular Medicine.
[9] D. Baker,et al. Senescent cells: an emerging target for diseases of ageing , 2017, Nature Reviews Drug Discovery.
[10] Pascal J. Goldschmidt-Clermont,et al. Aging, Progenitor Cell Exhaustion, and Atherosclerosis , 2003, Circulation.
[11] A. Tedgui,et al. Apoptotic cell death and efferocytosis in atherosclerosis. , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[12] Patrick M. McLendon,et al. Proteotoxicity and cardiac dysfunction. , 2015, Circulation research.
[13] Cam Patterson,et al. Proteotoxicity and cardiac dysfunction--Alzheimer's disease of the heart? , 2013, The New England journal of medicine.
[14] E. Braunwald. Coronary plaque erosion: recognition and management. , 2013, JACC. Cardiovascular imaging.
[15] C. Daige,et al. Macrophage Liver X Receptor Is Required for Antiatherogenic Activity of LXR Agonists , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[16] J. Mehta,et al. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. , 2006, Cardiovascular research.
[17] Mark D. Huffman,et al. Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association , 2016, Circulation.
[18] R. Virmani,et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[19] Randall C. Thompson,et al. Is atherosclerosis fundamental to human aging? Lessons from ancient mummies. , 2014, Journal of cardiology.
[20] P. Libby,et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.
[21] M Juhani Junttila,et al. Sudden Cardiac Death Caused by Coronary Heart Disease , 2012, Circulation.
[22] Randall C. Thompson,et al. Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations , 2013, The Lancet.
[23] P. Stone,et al. Endothelial shear stress in the evolution of coronary atherosclerotic plaque and vascular remodelling: current understanding and remaining questions. , 2012, Cardiovascular research.
[24] D. Giddens,et al. Association of Wall Shear Stress with Coronary Plaque Progression and Transformation. , 2015, Interventional cardiology clinics.
[25] François Mach,et al. Inflammation and Atherosclerosis , 2004, Herz.
[26] P. Davies,et al. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology , 2009, Nature Clinical Practice Cardiovascular Medicine.
[27] K. Ley,et al. Endothelial Protective Monocyte Patrolling in Large Arteries Intensified by Western Diet and Atherosclerosis , 2017, Circulation research.
[28] Pascal J Goldschmidt-Clermont,et al. Loss of bone marrow-derived vascular progenitor cells leads to inflammation and atherosclerosis. , 2003, American heart journal.
[29] A. Orekhov,et al. Vascular Extracellular Matrix in Atherosclerosis , 2013, Cardiology in review.
[30] Qing Xu,et al. Fluid-Phase Pinocytosis of Native Low Density Lipoprotein Promotes Murine M-CSF Differentiated Macrophage Foam Cell Formation , 2013, PloS one.
[31] S. Yusuf,et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.
[32] M. Cybulsky,et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated , 2007, Nature Reviews Immunology.
[33] N. LeBrasseur,et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders , 2011, Nature.
[34] Steffen Jung,et al. Blood monocytes consist of two principal subsets with distinct migratory properties. , 2003, Immunity.
[35] Lale Tokgözoğlu,et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel , 2017, European heart journal.
[36] Traci L. Marin,et al. Sterol Regulatory Element Binding Protein 2 Activation of NLRP3 Inflammasome in Endothelium Mediates Hemodynamic-Induced Atherosclerosis Susceptibility , 2013, Circulation.
[37] Randall C. Thompson,et al. Genomic correlates of atherosclerosis in ancient humans. , 2014, Global heart.
[38] P. Libby. Inflammation in atherosclerosis , 2002, Nature.
[39] Renu Virmani,et al. Intraplaque hemorrhage and progression of coronary atheroma. , 2003, The New England journal of medicine.
[40] D. Goff,et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. , 2012, JAMA.
[41] M. Flather,et al. Inflammatory Differences in Plaque Erosion and Rupture in Patients With ST‐Segment Elevation Myocardial Infarction , 2017, Journal of the American Heart Association.
[42] E. Herderick,et al. Will periodic intravenous injections of conditioned bone marrow cells effectively reduce atherosclerosis? , 2012, Antioxidants & redox signaling.
[43] P. Libby,et al. Inflammation and Atherosclerosis , 2002, Circulation.
[44] A. Sheikh,et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2 , 2008, BMJ : British Medical Journal.
[45] J. Strong,et al. Natural history and risk factors of atherosclerosis in children and youth: the PDAY study. , 2002, Pediatric pathology & molecular medicine.
[46] Paul M Ridker,et al. Inflammation in atherosclerosis: from pathophysiology to practice. , 2009, Journal of the American College of Cardiology.
[47] J. Hewitt,et al. The role of lipids and lipoproteins in atherosclerosis. , 1950, Science.
[48] Junlei Chang,et al. Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states , 2017, Nature Medicine.
[49] J. Gillard,et al. Does Calcium Deposition Play a Role in the Stability of Atheroma? Location May Be the Key , 2007, Cerebrovascular Diseases.
[50] J. Mehta,et al. Age- and Hypertension-Associated Protein Aggregates in Mouse Heart Have Similar Proteomic Profiles , 2016, Hypertension.
[51] E. Edelman,et al. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. , 2007, Journal of the American College of Cardiology.
[52] E. Falk,et al. Mechanisms of Plaque Formation and Rupture , 2014 .
[53] M. Fornage,et al. Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.
[54] Young Mi Hong,et al. Atherosclerotic Cardiovascular Disease Beginning in Childhood , 2010, Korean circulation journal.
[55] Claire E. Berryman,et al. Atherosclerotic Cardiovascular Disease , 2012 .
[56] P. Libby,et al. Requiem for the 'vulnerable plaque'. , 2015, European heart journal.
[57] A. Pezeshki,et al. Naturally occurring p16Ink4a-positive cells shorten healthy lifespan , 2016, Nature.
[58] M. Creager,et al. Atherosclerosis 2005: recent discoveries and novel hypotheses. , 2005, Circulation.
[59] J. Otto,et al. Prevalence of and risk factors for autopsy-determined atherosclerosis among US service members, 2001-2011. , 2012, JAMA.
[60] C. Hedrick,et al. Nonclassical patrolling monocyte function in the vasculature. , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[61] Kai Yin,et al. Foam cells in atherosclerosis. , 2013, Clinica chimica acta; international journal of clinical chemistry.
[62] S. Gabriel,et al. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease , 2017, The New England journal of medicine.
[63] M. Civelek,et al. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro , 2010, Proceedings of the National Academy of Sciences.
[64] V. Fuster,et al. Smoking gun theory: angiographically normal or mild coronary plaque as a cause of myocardial infarction. , 2012, Circulation.
[65] R. Virmani,et al. Plaque Rupture and Plaque Erosion , 1999, Thrombosis and Haemostasis.
[66] K. Moore,et al. Macrophages in the Pathogenesis of Atherosclerosis , 2011, Cell.
[67] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[68] Silvano Sozzani,et al. Nomenclature of monocytes and dendritic cells in blood. , 2010, Blood.
[69] J. Dunn,et al. Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis. , 2014, The Journal of clinical investigation.
[70] B. Passlick,et al. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. , 1989, Blood.
[71] M. West,et al. Molecular evidence for arterial repair in atherosclerosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[72] Randall C. Thompson,et al. Why did ancient people have atherosclerosis?: from autopsies to computed tomography to potential causes. , 2014, Global heart.
[73] B. Ebert,et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. , 2015, Blood.
[74] W F ENOS,et al. Coronary disease among United States soldiers killed in action in Korea; preliminary report. , 1953, Journal of the American Medical Association.
[75] R. Krauss,et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease , 2018 .
[76] S. Gordon,et al. Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.
[77] P. Libby,et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. , 2007, The Journal of clinical investigation.
[78] Udo Hoffmann,et al. Comprehensive plaque assessment by coronary CT angiography , 2014, Nature Reviews Cardiology.
[79] Wei Liu,et al. Phenotypic switching of vascular smooth muscle cells in the ‘normal region’ of aorta from atherosclerosis patients is regulated by miR‐145 , 2016, Journal of cellular and molecular medicine.
[80] Bernd Hewing,et al. High-density lipoprotein function, dysfunction, and reverse cholesterol transport. , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[81] A. Tall,et al. Activation of Liver X Receptor Decreases Atherosclerosis in Ldlr−/− Mice in the Absence of ATP-Binding Cassette Transporters A1 and G1 in Myeloid Cells , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[82] S. Hsiao,et al. Mechanoresponsive networks controlling vascular inflammation. , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[83] M J Davies,et al. The pathophysiology of acute coronary syndromes , 2000, Heart.
[84] G. Norata,et al. LOX-1, OxLDL, and Atherosclerosis , 2013, Mediators of inflammation.
[85] A. Sato,et al. Comparison of change in coronary atherosclerosis in patients with stable versus unstable angina pectoris receiving statin therapy (from the Treatment With Statin on Atheroma Regression Evaluated by Intravascular Ultrasound With Virtual Histology [TRUTH] study). , 2013, The American journal of cardiology.
[86] Klaus Ley,et al. Monocyte and macrophage dynamics during atherogenesis. , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[87] Brenda S. Hijmans,et al. A systems biology approach reveals the physiological origin of hepatic steatosis induced by liver X receptor activation , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[88] S. Pan,et al. Molecular mechanisms responsible for the atheroprotective effects of laminar shear stress. , 2009, Antioxidants & redox signaling.
[89] D. Levy,et al. Combating the epidemic of heart disease. , 2012, JAMA.
[90] B. Chen,et al. Shear Stress Activation of SREBP1 in Endothelial Cells Is Mediated by Integrins , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[91] M. Miyazaki,et al. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia*s⃞ , 2009, Journal of lipid research.
[92] P. Barter,et al. Dysfunctional HDL and atherosclerotic cardiovascular disease , 2016, Nature Reviews Cardiology.
[93] S. Chien,et al. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. , 2011, Physiological reviews.
[94] C. Conover,et al. Senescent intimal foam cells are deleterious at all stages of atherosclerosis , 2016, Science.
[95] K. Vickers,et al. The Role of Lipids and Lipoproteins in Atherosclerosis , 2015 .
[96] K. Moore,et al. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. , 2010, Cell metabolism.
[97] H. Yoshida,et al. Mechanisms of LDL oxidation. , 2010, Clinica chimica acta; international journal of clinical chemistry.
[98] Qingbo Xu. Disturbed flow-enhanced endothelial turnover in atherosclerosis. , 2009, Trends in cardiovascular medicine.
[99] J. Issa,et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. , 1999, Cardiovascular research.
[100] Clinton S. Robbins,et al. Monocyte fate in atherosclerosis. , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[101] J. Strong,et al. Origin of atherosclerosis in childhood and adolescence. , 2000, The American journal of clinical nutrition.
[102] P. Eshtehardi,et al. Protective or destructive: High wall shear stress and atherosclerosis. , 2016, Atherosclerosis.
[103] Jennifer G. Robinson,et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.
[104] F. Geissmann,et al. Monocytes in atherosclerosis: subsets and functions , 2010, Nature Reviews Cardiology.
[105] Jennifer G. Robinson,et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.
[106] C. Plass,et al. Methylation of the estrogen receptor-alpha gene promoter is selectively increased in proliferating human aortic smooth muscle cells. , 2000, Cardiovascular research.
[107] D. Ramji,et al. Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets , 2015, Cytokine & growth factor reviews.
[108] Achmad Rudijanto,et al. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. , 2007, Acta medica Indonesiana.
[109] D. Ingram,et al. Clinical significance of monocyte heterogeneity , 2015, Clinical and Translational Medicine.
[110] O. Velazquez,et al. Atherosclerosis, Inflammation, Genetics, and Stem Cells: 2012 Update , 2012, Current Atherosclerosis Reports.
[111] K. Moore,et al. Loss of SR-A and CD36 Activity Reduces Atherosclerotic Lesion Complexity Without Abrogating Foam Cell Formation in Hyperlipidemic Mice , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[112] P. Libby. Assisted Living in the Atheroma: Elderly Macrophages Promote Plaques. , 2016, Cell metabolism.
[113] J. Mehta,et al. Deletion of LOX-1 Reduces Atherogenesis in LDLR Knockout Mice Fed High Cholesterol Diet , 2007, Circulation research.